Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
10/2001
10/10/2001EP1141237A1 Pth receptor and screening assay utilizing the same
10/10/2001EP1141027A1 Antagonists of tweak and of tweak receptor and their use to treat immunological disorders
10/10/2001EP1141026A1 Compositions and methods for generating monoclonal antibodies representative of a specific cell type
10/10/2001EP1141025A1 Novel hyaluronan-binding proteins and encoding genes
10/10/2001EP1141023A2 Anti-cd3 immunotoxins and therapeutic uses therefor
10/10/2001EP1141022A1 Serine protease inhibitor
10/10/2001EP1141021A1 Removal/purification of serum albumins
10/10/2001EP1141020A2 Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof
10/10/2001EP1141019A2 Substance for producing highly effective anti-tumour medicaments and corresponding method
10/10/2001EP1141018A2 Peptides of the at1 receptor and their use for preeclampsia and malign hypertension
10/10/2001EP1141017A2 Characterization of the soc/crac calcium channel protein family
10/10/2001EP1141016A1 Three dimensional structure of a sterile alpha motif domain
10/10/2001EP1141015A1 Insulin-like growth factor (igf) i mutant variants
10/10/2001EP1141014A1 Insulin-like growth factor (igf) i mutant variants
10/10/2001EP1141013A2 EXPRESSION AND EXPORT OF ANTI-OBESITY PROTEINS AS Fc FUSION PROTEINS
10/10/2001EP1141012A1 Modification of interferon alpha production
10/10/2001EP1141011A2 Compounds and methods to inhibit or augment an inflammatory response
10/10/2001EP1141010A1 Human wnt-7a polypeptide and polynucleotide
10/10/2001EP1141009A2 Reagents and methods useful for detecting diseases of the breast
10/10/2001EP1141008A1 Class ii cytokine receptor-like proteins and nucleic acids encoding them
10/10/2001EP1141007A1 Compositions and methods for enhancement of major histocompatibility complex class i restricted antigen presentation
10/10/2001EP1141006A1 Topoisomerase ii inhibitor
10/10/2001EP1141005A1 Hypoxia-inducible factor 1alpha hif-1alpha variants and methods for identifying hif-1alpha modulators
10/10/2001EP1141002A1 Human cervical cancer 1 protooncogene and protein encoded therein
10/10/2001EP1141000A1 Superantigens
10/10/2001EP1140999A1 $i(CHLAMYDIA) ANTIGENS AND CORRESPONDING DNA FRAGMENTS AND USES THEREOF
10/10/2001EP1140998A1 $i(CHLAMYDIA) ANTIGENS AND CORRESPONDING DNA FRAGMENTS AND USES THEREOF
10/10/2001EP1140997A2 Chlamydia trachomatis antigens
10/10/2001EP1140996A2 Type iii secretion system antigens from bordetella pertussis
10/10/2001EP1140995A2 Peptides for inhibiting hbv core proteins
10/10/2001EP1140994A1 Outer surface proteins, their genes, and their use
10/10/2001EP1140990A1 Penicillins as pharmaceuticals for the downregulation of ifn gamma production
10/10/2001EP1140988A1 Halovir, an antiviral marine natural product, and derivatives thereof
10/10/2001EP1140987A1 Peptides for inhibiting hpv e6 proteins
10/10/2001EP1140980A1 Pseudopeptide compounds having an inhibiting activity with respect to paths activated by proteins with active tyrosine kinase activity and pharmaceutical compositions containing same
10/10/2001EP1140978A1 Methods of identifying antigen gene sequences
10/10/2001EP1140976A2 Secreted proteins and uses thereof
10/10/2001EP1140975A1 Stable subtilin and methods of manufacture
10/10/2001EP1140974A1 Neutralizing assay using human papillomavirus virus-like particles
10/10/2001EP1140973A1 Protein-protein interactions in neurodegenerative disorders
10/10/2001EP1140970A1 47 human secreted proteins
10/10/2001EP1140969A1 Connective tissue growth factor fragments and methods and uses thereof
10/10/2001EP1140968A1 Dna molecules encoding splice variants of the human melanocortin 1 receptor protein
10/10/2001EP1140964A2 Connective tissue growth factor fragments and methods and uses thereof
10/10/2001EP1140202A1 Peptidic product, process and composition
10/10/2001EP1140174A1 Agonists or antagonists of cutaneous t cell-attracting chemokine (ctack) or vasoactive intestinal contractor (vic) chemokines
10/10/2001EP1140173A2 Vascular endothelial cell growth factor antagonists and uses thereof
10/10/2001EP1140171A1 Methods and products for regulating lectin complement pathway associated complement activation
10/10/2001EP1140164A2 Multivalent immunogenic composition containing rsv subunit composition and influenza virus preparation
10/10/2001EP1140161A1 Synthetic virus-like particles with heterologous epitopes
10/10/2001EP1140158A2 Multi-component vaccine comprising at least two antigens from haemophilus influenzae
10/10/2001EP1140157A2 Streptococcus pneumoniae proteins and immunogenic fragments for vaccines
10/10/2001EP1140155A1 Improved recombinant hepatitis b surface antigen
10/10/2001EP1140153A2 Improvement of tolerance to a xenograft
10/10/2001EP1140150A2 Method for accelerating the rate of mucociliary clearance by using a kunitz-type serine protease inhibitor
10/10/2001EP1140148A1 Shelf-stable formulation of glucagon-like peptide-1
10/10/2001EP1140146A1 Porcine b7-1 and antibodies thereto
10/10/2001EP1140145A2 Novel exendin agonist formulations and methods of administration thereof
10/10/2001EP1140144A2 Composition of highly purified natural mixtures of type i interferon derived from leukocytes and methods
10/10/2001EP1140141A2 Methods for treating cancer and for mediating chemotaxis of dendritic cells
10/10/2001EP1140138A2 Therapeutic applications of flint polypeptides
10/10/2001EP1140136A2 Compositions and methods for the prevention or treatment of cancer and bone loss associated with cancer
10/10/2001EP1140133A1 Controlled release formulation comprising gnrh-ii
10/10/2001EP1140131A2 Peptides and peptide analogues designed from hfe protein and their uses in the treatment of iron overload diseases
10/10/2001EP1140130A2 Inhibition of angiogenesis by high molecular weight kininogen domain 3 peptide analogs
10/10/2001EP1140129A1 Human mad proteins and uses thereof
10/10/2001EP1140120A2 Human brainiac-5
10/10/2001EP1140045A2 Homer a new target of treating psychiatric disorders
10/10/2001EP1140023A2 Integrative protein-dna cochleate formulations and methods for transforming cells
10/10/2001EP1139750A1 Bone sialoprotein based toxic gene therapy for the treatment of calcified tumors and tissues
10/10/2001EP1139732A1 Msh5 ablated mice and uses therefor
10/10/2001EP0956036A4 Anti-fibrotic agent assay
10/10/2001EP0830372B1 Cyclic prodrugs of peptides and peptide nucleic acids having improved metabolic stability and cell membrane permeability
10/10/2001EP0672157B1 Recombinant viruses comprising artificial proteolytic cleavage site
10/10/2001EP0668909B1 Transgenic, cross-linked hemoglobin
10/10/2001CN1317054A Constitutive disease resistance gene (CDR1) and method of use thereof
10/10/2001CN1317052A Proteases fused with variants of streptomyces subtilisin proteases inhibitor
10/10/2001CN1317047A GBS toxin receptor
10/10/2001CN1317046A Novel receptor protein and method for diagnosing inflammatory diseases by using the same
10/10/2001CN1317044A Nucleic acids encoding proteins involved in sensory transduction
10/10/2001CN1317043A Polypeptides and polynucleotides from coagulase-negative staphylocoui
10/10/2001CN1317014A Antibody for detecting microorganism
10/10/2001CN1317013A Peptide fragments of cholera toxic B or enterotoxin B as vaccine adjuvants
10/10/2001CN1317010A Nucleic acids encoding G-protein coupled receptor involved in sensory
10/10/2001CN1316910A Composition and methods for regulating lymphocyte activation
10/10/2001CN1316906A Stable liquid formulations of botulinum toxin
10/10/2001CN1316516A Coded rpilk gene nucleotide sequence and its using method
10/10/2001CN1316515A Human liver cancer related cancer suppressing protein and its coding sequence
10/10/2001CN1316436A Process for preparing water-soluble slow-releasing recombination protein
10/10/2001CN1316435A Human testicular development specificity protein-8 gene coding protein
10/10/2001CN1316434A Human specific protein kinase-15 gene coding protein
10/10/2001CN1316433A Human exonuclease factor gene coding protein
10/10/2001CN1316432A Cell death inhibitory albumen
10/10/2001CN1316431A Compound of polypeptide as antigen of hepatitis B virus and heat shock protein and its application
10/10/2001CN1072720C Chicken growth hormone gene and expression thereof in E. Coli
10/10/2001CN1072719C Isolated nucleic acid sequence coding for tumor rejection antigen precursor
10/10/2001CN1072718C Lipase and its micro-organism process for producing the lipase, and use
10/10/2001CA2302861A1 Signal peptides nucleic acid molecules and methods for treatment of caries
10/09/2001WO2000066625A1 Soybean protein nutraceuticals
10/09/2001US6300540 Genetically engineered rodent model; for use in diagnosis an treatment of alzheimer's disease
1 ... 1954 1955 1956 1957 1958 1959 1960 1961 1962 1963 1964 1965 1966 1967 1968 1969 1970 1971 1972 1973 1974 ... 2916